Is luteinizing hormone-releasing hormone agonist justified in short adolescents?

N Engl J Med. 2003 Jul 10;349(2):192-3; author reply 192-3. doi: 10.1056/NEJM200307103490218.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adolescent
  • Bone Density / drug effects*
  • Growth Disorders / diagnosis
  • Growth Disorders / drug therapy*
  • Humans
  • Triptorelin Pamoate / pharmacology
  • Triptorelin Pamoate / therapeutic use*

Substances

  • Triptorelin Pamoate